PT1451184E - Compostos diméricos e sua utilização como agentes antivirais - Google Patents
Compostos diméricos e sua utilização como agentes antivirais Download PDFInfo
- Publication number
- PT1451184E PT1451184E PT02774169T PT02774169T PT1451184E PT 1451184 E PT1451184 E PT 1451184E PT 02774169 T PT02774169 T PT 02774169T PT 02774169 T PT02774169 T PT 02774169T PT 1451184 E PT1451184 E PT 1451184E
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- dimetric
- aging agents
- trifluoroacetyl
- acetyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR8795A AUPR879501A0 (en) | 2001-11-09 | 2001-11-09 | Novel chemical compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1451184E true PT1451184E (pt) | 2008-09-17 |
Family
ID=3832614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02774169T PT1451184E (pt) | 2001-11-09 | 2002-11-08 | Compostos diméricos e sua utilização como agentes antivirais |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7230028B2 (https=) |
| EP (1) | EP1451184B1 (https=) |
| JP (2) | JP5178989B2 (https=) |
| KR (1) | KR100942493B1 (https=) |
| CN (1) | CN1301993C (https=) |
| AT (1) | ATE398123T1 (https=) |
| AU (1) | AUPR879501A0 (https=) |
| CA (1) | CA2462345C (https=) |
| DE (1) | DE60227101D1 (https=) |
| DK (1) | DK1451184T3 (https=) |
| ES (1) | ES2305301T3 (https=) |
| PT (1) | PT1451184E (https=) |
| WO (1) | WO2003040138A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| ES2911027T3 (es) | 2015-11-20 | 2022-05-17 | AusVir Therapeutics Pty Ltd | Compuestos para aplicaciones medicinales |
| CN115197583B (zh) | 2017-02-10 | 2024-03-15 | 三菱化学株式会社 | 导电性组合物、导电性组合物的制造方法和导电体的制造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE193551T1 (de) * | 1991-03-18 | 2000-06-15 | Scripps Research Inst | Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen |
| GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
| CA2245680C (en) * | 1996-03-01 | 2005-09-27 | Biota Scientific Management Pty. Ltd. | Method of detection of influenza virus and compounds for use therein |
| AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
-
2001
- 2001-11-09 AU AUPR8795A patent/AUPR879501A0/en not_active Abandoned
-
2002
- 2002-11-08 PT PT02774169T patent/PT1451184E/pt unknown
- 2002-11-08 ES ES02774169T patent/ES2305301T3/es not_active Expired - Lifetime
- 2002-11-08 WO PCT/AU2002/001528 patent/WO2003040138A1/en not_active Ceased
- 2002-11-08 KR KR1020047006445A patent/KR100942493B1/ko not_active Expired - Fee Related
- 2002-11-08 DE DE60227101T patent/DE60227101D1/de not_active Expired - Lifetime
- 2002-11-08 AT AT02774169T patent/ATE398123T1/de not_active IP Right Cessation
- 2002-11-08 US US10/494,241 patent/US7230028B2/en not_active Expired - Fee Related
- 2002-11-08 EP EP02774169A patent/EP1451184B1/en not_active Expired - Lifetime
- 2002-11-08 CN CNB028222490A patent/CN1301993C/zh not_active Expired - Fee Related
- 2002-11-08 CA CA2462345A patent/CA2462345C/en not_active Expired - Fee Related
- 2002-11-08 JP JP2003542184A patent/JP5178989B2/ja not_active Expired - Fee Related
- 2002-11-08 DK DK02774169T patent/DK1451184T3/da active
-
2007
- 2007-05-21 US US11/751,269 patent/US7795301B2/en not_active Expired - Fee Related
-
2010
- 2010-07-16 JP JP2010161643A patent/JP5179546B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2462345C (en) | 2011-10-18 |
| EP1451184A1 (en) | 2004-09-01 |
| JP5178989B2 (ja) | 2013-04-10 |
| EP1451184A4 (en) | 2005-02-02 |
| WO2003040138A1 (en) | 2003-05-15 |
| JP5179546B2 (ja) | 2013-04-10 |
| JP2005511610A (ja) | 2005-04-28 |
| CA2462345A1 (en) | 2003-05-15 |
| DK1451184T3 (da) | 2008-10-27 |
| JP2011006424A (ja) | 2011-01-13 |
| EP1451184B1 (en) | 2008-06-11 |
| AUPR879501A0 (en) | 2001-12-06 |
| US7795301B2 (en) | 2010-09-14 |
| KR20050044338A (ko) | 2005-05-12 |
| US20050043399A1 (en) | 2005-02-24 |
| KR100942493B1 (ko) | 2010-02-12 |
| US20070225359A1 (en) | 2007-09-27 |
| US7230028B2 (en) | 2007-06-12 |
| CN1301993C (zh) | 2007-02-28 |
| ES2305301T3 (es) | 2008-11-01 |
| HK1068344A1 (en) | 2005-04-29 |
| ATE398123T1 (de) | 2008-07-15 |
| CN1585767A (zh) | 2005-02-23 |
| DE60227101D1 (de) | 2008-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035927A1 (es) | Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr | |
| MXPA03005464A (es) | Agentes antivirales. | |
| FR2805817B1 (fr) | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation | |
| IL159087A0 (en) | Bridged bicyclic compounds and pharmaceutical compositions containing the same | |
| BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
| NO20044895L (no) | Substituerte cykloalkyl P1' hepatitt C virus inhibitorer | |
| BR0115447A (pt) | Inibidores de tripeptìdeo de hepatite c | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| GEP20053619B (en) | Pyrazole Derivatives for Treating HIV | |
| DE69529670D1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| FR2762843B1 (fr) | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| SE9902765D0 (sv) | Novel compounds | |
| SE0102055D0 (sv) | New Compounds | |
| SE0101322D0 (sv) | Novel compounds | |
| EP1019047A4 (en) | ANTITHROMBOTIC AGENTS | |
| PT1451184E (pt) | Compostos diméricos e sua utilização como agentes antivirais | |
| ATE286395T1 (de) | Antithrombotische mittel | |
| PT1411956E (pt) | Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih | |
| PT1451181E (pt) | Compostos diméricos e sua utilização como agentes antivirais | |
| ATE301997T1 (de) | Antivirale therapie | |
| DE60008430D1 (de) | Verbindungen mit antithrombotischer wirkung | |
| ATE270886T1 (de) | Antivirale therapie | |
| GB0223234D0 (en) | Chemical compounds |